Detection of urinary markers for thiazide diuretics after oral administration of hydrochlorothiazide and altizide-relevance to doping control analysis

Journal of Chromatography A

Volumn 1216, Issue 12, 2009, Pages 2466-2473

  Deventer, K ^a   Pozo, O J ^a   Van Eenoo, P ^a   Delbeke, F T ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

Diuretics; Doping; LC MS; Thiazides; Urine

Indexed keywords

DIURETICS; DOPING; LC-MS; THIAZIDES; URINE;

AMINATION; AMINES; DOPING (ADDITIVES); HYDROLYSIS; METABOLISM; METABOLITES;

BODY FLUIDS;

4 AMINO 6 CHLORO 1,3 BENZENEDISULPHONAMIDE; ALDACTAZINE; ALTIZIDE; CHLOROTHIAZIDE; DOCSPIROCHLOR; HYDROCHLOROTHIAZIDE; THIAZIDE DIURETIC AGENT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; DIURESIS; DOPING; DRUG ELIMINATION; DRUG EXCRETION; DRUG STRUCTURE; DRUG URINE LEVEL; FEMALE; HUMAN; HUMAN EXPERIMENT; HYDROLYSIS; LIQUID CHROMATOGRAPHY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY; URINARY EXCRETION;

ADMINISTRATION, ORAL; ADULT; BENZOTHIADIAZINES; BIOMARKERS, PHARMACOLOGICAL; CHLOROTHIAZIDE; CHROMATOGRAPHY, LIQUID; DIURETICS; DOPING IN SPORTS; FEMALE; HUMANS; HYDROCHLOROTHIAZIDE; LEAST-SQUARES ANALYSIS; LINEAR MODELS; MALE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SODIUM CHLORIDE SYMPORTER INHIBITORS; SULFANILAMIDES; TANDEM MASS SPECTROMETRY;

EID: 60949100674     PISSN: 00219673     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chroma.2009.01.032     Document Type: Article

References (21)

1. Rang H.P., Dale M.M., and Ritter J.M. Pharmacology (1995), Churchill Livingstone, New York
2. Delbeke F.T., and Debackere M. Biopharm. Drug Dispos. 9 (1988) 137
3. WADA (World Anti-Doping Agency), The world anti-doping code, The 2008 prohibited list, Montreal (2008). .
4. WADA (World Anti-Doping Agency), Technical document: minimum required performance limits for detection of prohibited substances: TD2004MRPL, Montreal (2004). .
5. Goebel C., Trout G.J., and Kazlauskas R. Anal. Chim. Acta 502 (2004) 65
6. Thieme D., Grosse J., Lang R., Mueller R.K., and Wahl A. J. Chromatogr. B 757 (2001) 49
7. Deventer K., Baele G., Van Eenoo P., Pozo O.J., and Delbeke F.T. J. Pharm. Biomed. Anal 49 (2009) 519-524
8. Welling P.G. Biopharm. Drug Dispos 7 (1986) 501
9. Okuda T., Itoh S., Yamazaki M., Nakahama H., Fukuhara Y., and Orita Y. Chem. Pharm. Bull. 35 (1987) 3516
10. Beermann B., Groschinskygrind M., and Rosen A. Clin. Pharmacol. Ther. 19 (1976) 531
11. Farthing D., Fakhry I., Ripley E.B.D., and Sica D. J. Pharm. Biomed. Anal. 17 (1998) 1455
12. Doignon J.L., Grognet J.M., Thebault J.J., Caplain M., Capron M.H., Pelletier B., Wehrlen M., and Istin M. Therapie 45 (1990) 475
13. Verwaal W., van Bavel M., Boot A., Bravenboer J., de Goei F., Maas C., and van der Putten A. De Ware(n) Chemicus (1996)
14. Bressolle F., BrometPetit M., and Audran M. J. Chromatogr. B 686 (1996) 3
15. Van Eenoo P., Lootens L., Spaerkeer A., Van Thuyne W., Deventer K., and Delbeke F.T. J. Anal. Toxicol. 31 (2007) 543
16. Deventer K., Delbeke F.T., Roels K., and Van Eenoo P. Biomed. Chromatogr. 16 (2002) 529
17. Ventura R., and Segura J. J. Chromatogr. B 687 (1996) 127
18. Angel M.J.R., Agusti M.T.G., Romero J.S.E., and Broch S.C. LC-GC Eur. 18 (2005) 32
19. Thevis M., Schmickler H., and Schanzer W. Anal. Chem. 74 (2002) 3802
20. Barbhaiya R.H., Phillips T.A., and Welling P.G. J. Pharm. Sci. 70 (1981) 291
21. Yamazaki M., Ito Y., Suzuka T., Yaginuma H., Itoh S., Kamada A., Orita Y., Nakahama H., Nakanishi T., and Ando A. Chem. Pharm. Bull. 32 (1984) 2387